Early Defects in Human T-cell Development Severely Affect Distribution and Maturation of Thymic Stromal Cells: Possible Implications for the Pathophysiology of Omenn Syndrome
Overview
Authors
Affiliations
Thymocytes and thymic epithelial cell (TEC) cross-talk is crucial to preserve thymic architecture and function, including maturation of TECs and dendritic cells, and induction of mechanisms of central tolerance. We have analyzed thymic maturation and organization in 9 infants with various genetic defects leading to complete or partial block in T-cell development. Profound abnormalities of TEC differentiation (with lack of AIRE expression) and severe reduction of thymic dendritic cells were identified in patients with T-negative severe combined immunodeficiency, reticular dysgenesis, and Omenn syndrome. The latter also showed virtual absence of thymic Foxp3(+) T cells. In contrast, an IL2RG-R222C hypomorphic mutation permissive for T-cell development allowed for TEC maturation, AIRE expression, and Foxp3(+) T cells. Our data provide evidence that severe defects of thymopoiesis impinge on TEC homeostasis and may affect deletional and nondeletional mechanisms of central tolerance, thus favoring immune dysreactive manifestations, as in Omenn syndrome.
Pasternak Y, Vong L, Merico D, Abrego Fuentes L, Scott O, Sham M J Allergy Clin Immunol Glob. 2024; 3(3):100267.
PMID: 38800615 PMC: 11127205. DOI: 10.1016/j.jacig.2024.100267.
Interferon autoantibodies as signals of a sick thymus.
Oftedal B, Sjogren T, Wolff A Front Immunol. 2024; 15:1327784.
PMID: 38455040 PMC: 10917889. DOI: 10.3389/fimmu.2024.1327784.
Primary and secondary defects of the thymus.
Dinges S, Amini K, Notarangelo L, Delmonte O Immunol Rev. 2024; 322(1):178-211.
PMID: 38228406 PMC: 10950553. DOI: 10.1111/imr.13306.
Human autoantibodies neutralizing type I IFNs: From 1981 to 2023.
Bastard P, Gervais A, Le Voyer T, Philippot Q, Cobat A, Rosain J Immunol Rev. 2024; 322(1):98-112.
PMID: 38193358 PMC: 10950543. DOI: 10.1111/imr.13304.
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency.
Le Voyer T, Parent A, Liu X, Cederholm A, Gervais A, Rosain J Nature. 2023; 623(7988):803-813.
PMID: 37938781 PMC: 10665196. DOI: 10.1038/s41586-023-06717-x.